🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Full house for the oral presentation session advances in clinical practice for rare ILDs in Room A3 #ERScongress Pilar Rivera-Ortega

Great talks and high quality of research in rare-ILDs! Thanks to all participants and chairs#ERS2024 ERS Assembly 12 - ILD

Take your sandwich to the interesting ILD poster sessions #ERScongress

Even the overflow area is full for the ILD state if the art session #ERScongress

Lungs on fire. Come and enjoy these interesting cases #ERSCongress

Looking forward to meeting you at this session on novel management strategies in pulmonary fibrosis Room A1 #ERSCongress

I hope you enjoyed meeting us! Please fill out the form above and keep your competencies list up to date on Myers' profile.

Breaking news in ILD of known origin. Join us now in room Strauss 1! #ERSCongress

Great presentations and discussion in Breaking News in ILD! #ERSCongress2024 ERS Assembly 12 - ILD

From omics to clinical care in ILD, now in Room A3. Don't miss it! #ERSCongress2024

Very busy poster sessions ongoing, PS28-29-30! Welcome to join the discussions #ERSCongress

Interesting joint lecture format with pulmonologist Michael Kreuter and rheumatologist Anna Hoffmann-Vold discussing #ILD and the value of multidisciplinary teams 🫁 #ERSCongress

What a great Tuesday! 4 amazing ILD symposia/hot topic sessions on one day, followed by our Assembly meeting and networking event💪 So nice to meet many ILD colleagues in person in beautiful Vienna #ERSCongress2024 ERS

Do not miss it! We all encounter these challenging questions in our daily practice #ERSCongress2024

Hard core ILD group left at the very end of #ERSCongress2024 Pilar Rivera-Ortega

Thanks for a fantastic ERS congress. We've had so many inspiring ILD sessions and were very happy to meet old friends and new (young) colleagues! Safe trip back home and see you in Amsterdam next year. #ERSCongress2024 #Assembly12 Michael Kreuter Katerina Antoniou Karen Moor

Cannot wait to see the data from the FIBRONEER Phase III trial of nerandomilast in IPF! This is a very exciting development on the back of all the earlier Phase II study results... And a very timely announcement in the middle of PF awareness month!

🚨 Only 2 weeks left to apply for the ECM Mentoring Programme! 🚨 If you applied before Jan 15, please resubmit your application to ensure it's received. Don't miss this opportunity—apply now!

سعدت بالمشاركة🇸🇦 في كتابة هذه الورقة مع نخبة من الباحثين المتميزين من هولندا، ألمانيا، بريطانيا، وإيطاليا، والمنشور في ERJ Open Research. Karen Moor Laura Fabbri Our latest article has been published in ERJ Open Research! It was a pleasure to work with Dr Laura, Karen, Prof.

Presented at #ATS2025: In the PREDMETH trial, first-line treatment of pulmonary sarcoidosis with methotrexate was noninferior to that with prednisone regarding the change at 24 weeks in the percentage of the predicted forced vital capacity. Full trial results: